US Stock MarketDetailed Quotes
VRPX Virpax Pharmaceuticals
- 0.4000
- +0.0991+32.93%
Close Dec 13 16:00 ET
- 0.3768
- -0.0232-5.80%
Post 20:01 ET
3.24MMarket Cap-0.06P/E (TTM)
0.4800High0.2860Low9.65MVolume0.3100Open0.3009Pre Close3.97MTurnover123.88%Turnover RatioLossP/E (Static)8.09MShares5.480052wk High-1.57P/B3.11MFloat Cap0.286052wk Low--Dividend TTM7.79MShs Float360.0000Historical High--Div YieldTTM64.47%Amplitude0.2860Historical Low0.4110Avg Price1Lot Size
About Virpax Pharmaceuticals Company
Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
Company Profile
SymbolVRPX
Company NameVirpax Pharmaceuticals
Listing DateFeb 17, 2021
Issue Price10.00
Founded2017
CEOMr. Jatinder Dhaliwal
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address1055 Westlakes Drive,Suite 300
CityBerwyn
ProvincePennsylvania
CountryUnited States of America
Zip Code19312
Phone1-610-727-4597
Websitehttp://www.virpaxpharma.com
Company Executives
- Name
- Position
- Salary
- Jatinder Dhaliwal
- Director and Chief Executive Officer
- --
- Dr. Sheila A. Mathias, J.D.,M.B.A.,PhD
- Chief Scientific Officer
- 498.00K
- Usama Chaudhry
- Chief Financial Officer
- --
- Katharyn Field
- Director, Vice President and Principal Executive Officer
- --
- Gary Herman
- Director
- --
- Judy Su
- Director
- --
- Esha Randhawa
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data
